Hold on to your shares: Terns Pharmaceuticals Inc (TERN) Stock

Mizuho raised the price target for the Terns Pharmaceuticals Inc (NASDAQ:TERN) stock to “a Buy”. The rating was released on June 22, 2023, according to finviz. The research report from ROTH MKM has initiated the stock to Buy, with a price target set at $23. The stock was initiated by BMO Capital Markets, who disclosed […]

Is this a gain, a loss, or a throwaway? Terns Pharmaceuticals Inc (TERN) Stock

Mizuho raised the price target for the Terns Pharmaceuticals Inc (NASDAQ:TERN) stock to “a Buy”. The rating was released on June 22, 2023, according to finviz. The research report from ROTH MKM has initiated the stock to Buy, with a price target set at $23. The stock was initiated by BMO Capital Markets, who disclosed […]

Terns Pharmaceuticals Inc (TERN) Stock Is Looking Attractive

Mizuho raised the price target for the Terns Pharmaceuticals Inc (NASDAQ:TERN) stock to “a Buy”. The rating was released on June 22, 2023, according to finviz. The research report from ROTH MKM has initiated the stock to Buy, with a price target set at $23. The stock was initiated by BMO Capital Markets, who disclosed […]

Why Terns Pharmaceuticals Inc (NASDAQ:TERN) Stock went down -29.45% in Last Year?

Mizuho raised the price target for the Terns Pharmaceuticals Inc (NASDAQ:TERN) stock to “a Buy”. The rating was released on June 22, 2023, according to finviz. The research report from ROTH MKM has initiated the stock to Buy, with a price target set at $23. The stock was initiated by BMO Capital Markets, who disclosed […]

Why Terns Pharmaceuticals Inc (NASDAQ:TERN) Stock Slipped -17.55% in Last Month?

Mizuho raised the price target for the Terns Pharmaceuticals Inc (NASDAQ:TERN) stock to “a Buy”. The rating was released on June 22, 2023, according to finviz. The research report from ROTH MKM has initiated the stock to Buy, with a price target set at $23. The stock was initiated by BMO Capital Markets, who disclosed […]

Mizuho Sets Terns Pharmaceuticals Inc (NASDAQ:TERN) Stock to “a Buy”

Mizuho raised the price target for the Terns Pharmaceuticals Inc (NASDAQ:TERN) stock to “a Buy”. The rating was released on June 22, 2023, according to finviz. The research report from ROTH MKM has initiated the stock to Buy, with a price target set at $23. The stock was initiated by BMO Capital Markets, who disclosed […]